DOCSLIB.ORG

TKS V02.00.04 20081024.Xls VERSION 1/196 VERSION 02.00

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
TKS V02.00.04 20081024.Xls VERSION 1/196 VERSION 02.00 TKS_V02.00.04_20081024.xls VERSION 1/196 VERSION 02.00.04 PUBLIC DATUM 24.10.2008 AUTOR GfKT - AG-V - c/o Stürer STATUS verabschiedet TDI-AG-III / c.o. A.Stürer TKS_V02.00.04_20081024.xls 03.05.2016 TKS_ID TKS_NAME TKS_NAME_DE LOCK TKS_CODE E1 E2 E3 E4 E5 E6 E7 E8 E9 TKS_DEFINITION_DE START_PUBLIC UPDATE_PUBLIC END MUTATION NOTE 4901020736 Erzeugnisse ja E E Alles, was irgendwie erzeugt und gehandelt wird 11.09.2006 4901020795 Bedarfsmittel ja EB E B Mit Ausnahme der Reinigungs- und Raumluftmittel 11.09.2006 4901020957 Bedarfsgegenstände (ohne Reinigungs- und Raumluftmittel) ja EBB E B B 11.09.2006 4908020958 Gegenstände für Körperpflege und längere Haut-/Körperberührung ja EBBH EBBH z.B. Bürsten, Schwämme, Handtücher... 11.09.2006 4908020959 Gegenstände zur Körperpflege nein EBBH01 EBBH01 11.09.2006 4908020960 Bekleidung nein EBBH02 EBBH02 11.09.2006 4908020961 Styling-Gegenstände ('Körper-Takelage') incl. Masken nein EBBH05 EBBH05 z.B. Schmuck,Haar-, Wimpern-, Nagel-Teile 11.09.2006 4908020967 Sitz- und Liegeflächen, Handgriffe nein EBBH11 EBBH11 z.B. Bettwäsche, Matratzen, Sitzmöbel 11.09.2006 4908020966 Gegenstände für Körperpflege und längere Haut-/Körperberührung - nicht klassifiziert nein EBBH95 EBBH95 z.B. Bürsten, Schwämme, Handtücher... 11.09.2006 4908020965 Kosmetika- und Tabak-Verpackungen nein EBBK EBBK 11.09.2006 4908020955 Gegenstände mit Lebensmittelberührung ja EBBL EBBL 11.09.2006 4908020963 Eß- und Kochgeschirr, Vorratsbehälter nein EBBL01 EBBL01 z.B.Bratpfannenbeschichtung, Babysauger und -fla 11.09.2006 4908020962 Lebensmittelverpackungen nein EBBL11 EBBL11 11.09.2006 4908020964 Gegenstände mit Lebensmittelberührung - nicht klassifiziert nein EBBL95 EBBL95 11.09.2006 4908020970 Mundstücke und andere Gegenstände für Gebrauch mit und im Mund nein EBBM EBBM z.B.Zahnstocher, -bürsten, Mundspatel,Babyschnu 11.09.2006 4908001142 Spielwaren und Scherzartikel ja EBBS EBBS 11.09.2006 4908001144 Spielwaren mit losen Stoffen/Füllungen nein EBBS01 EBBS01 11.09.2006 4908001145 Spielzeug-Stoffe/Füllungen - flüssig nein EBBS01F EBBS01F 11.09.2006 4908001146 Spielzeug-Füllungen - gasförmig nein EBBS01G EBBS01G 11.09.2006 4908001147 Spielzeug-Stoffe/Füllungen - andere nein EBBS01Y EBBS01Y 11.09.2006 4908001149 Spielwaren und Scherzartikel - nicht klassifiziert nein EBBS95 EBBS95 11.09.2006 4908020944 Bedarfsgegenstände (ohne Reinigungs- und Raumluftmittel) - nicht klassifiziert nein EBBZ EBBZ 11.09.2006 4901000330 Kosmetika ja EBK E B K 11.09.2006 4912000331 Haut-Kosmetika ja EBKD EBK D 11.09.2006 4912000334 Seifen nein EBKD05 EBKD05 11.09.2006 4912020796 Feinseifen nein EBKD05C EBKD05C 11.09.2006 4912020797 Flüssige Seife nein EBKD05F EBKD05F 11.09.2006 4912020798 Spezial Haut- und Handreinigungsmittel nein EBKD05I EBKD05I 11.09.2006 20.10.2008 20.10.2008 TKS_NAME (alt: Spezial Haut-und Handreinigungsmitel) 4912000337 Bade- und Duschprodukte nein EBKD10 EBKD10 11.09.2006 4912000338 Duschbäder / Schaumbäder nein EBKD10C EBKD10C 11.09.2006 4912000339 Pflegebäder nein EBKD10F EBKD10F 11.09.2006 4912020799 Bademilch nein EBKD10FC EBKD10FC 11.09.2006 4912020800 Badeöl (einschließlich Badeperlen) nein EBKD10FF EBKD10FF 11.09.2006 4912000340 Badesalz / Badetabletten nein EBKD10FI EBKD10FI 11.09.2006 4912020801 Fußbad nein EBKD10FL EBKD10FL 11.09.2006 4912000343 Hautcremes, -gele und -lotionen nein EBKD15 EBKD15 11.09.2006 20.10.2008 20.10.2008 TKS_NAME (alt:Hautcremes, -gele und - lotionen) 4912000344 Hautcreme nein EBKD15C EBKD15C 11.09.2006 4912020802 Handcreme nein EBKD15CC EBKD15CC 11.09.2006 4912020803 Babycreme nein EBKD15CF EBKD15CF 11.09.2006 4912020804 Zink- und Zinkrizinusölcreme (Emulsion) nein EBKD15CF05 EBKD15CF 05 11.09.2006 20.10.2008 20.10.2008 TKS_NAME (alt: Zink und Zinkrizinusölcreme (Emulsion)) 4912020805 Mineralische Fettcreme nein EBKD15CF10 EBKD15CF 10 11.09.2006 4912020806 Hautpflegende Gele und Lotionen nein EBKD15F EBKD15F 11.09.2006 4912020807 Babylotion und -milch nein EBKD15FC EBKD15FC 11.09.2006 20.10.2008 20.10.2008 TKS_NAME (alt: Babylotion und - milch) 4912020808 Feuchtigkeitsspendende Lotionen ( Moisturizer) oder Gele nein EBKD15FF EBKD15FF 11.09.2006 4912020809 Feuchtigkeitspendendes Pumpspray nein EBKD15FI EBKD15FI 11.09.2006 4912020810 Gesichtsmaske nein EBKD15FL EBKD15FL 11.09.2006 4912020811 Zellregenerierungslotionen und -gele nein EBKD15FO EBKD15FO 11.09.2006 4912020812 Kühl-Gele und sonstige Einreibungen nein EBKD15FR EBKD15FR 11.09.2006 4912020813 Hautreinigende Gele und Lotionen nein EBKD15I EBKD15I 11.09.2006 4912020814 Hautgel (einschließlich bakterizides Gel) nein EBKD15IC EBKD15IC 11.09.2006 4912020815 Handreinigungsgel nein EBKD15IF EBKD15IF 11.09.2006 4912020816 Gesichtswasser und -lotionen nein EBKD15II EBKD15II 11.09.2006 4912020817 Gesichtswasser nein EBKD15II05 EBKD15II 05 11.09.2006 4912020818 Gesichtslotion nein EBKD15II10 EBKD15II 10 11.09.2006 4912020819 Reinigungsemulsion für das Gesicht nein EBKD15II15 EBKD15II 15 11.09.2006 4912020820 Intimreinigungsgele und -lotionen nein EBKD15IL EBKD15IL 11.09.2006 20.10.2008 20.10.2008 TKS_NAME (alt: Intimreinigungsgele und -lotion) 4912020821 Antiseptisches Schaumgel / Intimreinigungsgel nein EBKD15IL05 EBKD15IL 05 11.09.2006 4912020822 Hautreinigungstücher nein EBKD15IO EBKD15IO 11.09.2006 4912020823 Baby-Feuchtigkeitstücher nein EBKD15IO05 EBKD15IO 05 11.09.2006 4912000345 Haut-Pflegeöle nein EBKD20 EBKD20 EVA-kompatibel auch Massageöle 11.09.2006 4912020824 Körperöl / Gesichtsöl nein EBKD20C EBKD20C 11.09.2006 4912020825 Babyöle und -tücher nein EBKD20CC EBKD20CC 11.09.2006 4912000346 Puder für Hautpflege nein EBKD25 EBKD25 11.09.2006 4912020826 Talkum [TALC] (pulverförmig oder gepresst) nein EBKD25C EBKD25C 11.09.2006 20.10.2008 20.10.2008 TKS_NAME (alt: Talkum [TALC] (pulverförmig oder gepreßt)) 4912020827 Pflegeprodukte in Kapseln nein EBKD30 EBKD30 11.09.2006 4912000347 Hautpflegemittel - nicht klassifiziert nein EBKD35 EBKD35 11.09.2006 20.10.2008 20.10.2008 TKS_NAME (alt: Hautpflegemittel, nicht kategorisiert) 4912000352 Sonnenschutzmittel nein EBKD40 EBKD40 11.09.2006 4912020828 Sonnenschutzcreme und -lotion nein EBKD40C EBKD40C 11.09.2006 4912020829 Sonnenschutzöl nein EBKD40F EBKD40F 11.09.2006 4912020830 Sonnenschutzstift nein EBKD40I EBKD40I 11.09.2006 4912020831 Sonnenschutzgel nein EBKD40L EBKD40L 11.09.2006 4912020832 Sonnenschutzhydrogel nein EBKD40LC EBKD40LC 11.09.2006 4912020833 Sonnenschutzgel auf Ölbasis nein EBKD40LF EBKD40LF 11.09.2006 4912000354 Selbstbräuner für die Haut nein EBKD40O EBKD40O 11.09.2006 4912020834 Selbstbräunungslotion und -creme nein EBKD40OC EBKD40OC 11.09.2006 20.10.2008 20.10.2008 TKS_NAME (alt: Selbstbräunungslotion und -Creme) 4912020835 Selbstbräunungsgel nein EBKD40OF EBKD40OF 11.09.2006 4912000359 Rasierprodukte nein EBKD45 EBKD45 11.09.2006 4912000360 Rasierseife / -schaum / -gel nein EBKD45C EBKD45C 11.09.2006 20.10.2008 20.10.2008 TKS_NAME (alt: Rasier-Seife / -Schaum/ -gel) 4912020836 Rasiercreme und pinsellose Rasiercreme nein EBKD45CC EBKD45CC 11.09.2006 4912020837 Rasiergel nein EBKD45CF EBKD45CF 11.09.2006 4912020838 Rasiergel (nachschäumend) nein EBKD45CI EBKD45CI 11.09.2006 4912020839 Rasierschaum - Aerosol nein EBKD45CL EBKD45CL 11.09.2006 4912020840 Rasierseife / Rasierstift nein EBKD45CO EBKD45CO 11.09.2006 4912000361 Aftershave nein EBKD45F EBKD45F 11.09.2006 20.10.2008 20.10.2008 TKS_NAME (alt: After-Shave) 4912020841 Aftershave Balsam nein EBKD45FC EBKD45FC 11.09.2006 20.10.2008 20.10.2008 TKS_NAME (alt: After-Shave-Balsam) 4912020842 Aftershave Lotion nein EBKD45FF EBKD45FF 11.09.2006 20.10.2008 20.10.2008 TKS_NAME (alt: After-Shave-Lotion) 4912020843 Parfüm und Erfrischungstücher nein EBKD50 EBKD50 11.09.2006 4912000365 Parfüm (Eau de Toilette und Eau de Parfum) nein EBKD50C EBKD50C 11.09.2006 4912020844 Erfrischungstücher nein EBKD50F EBKD50F 11.09.2006 4912000366 Deodorantien / Antitranspirantien nein EBKD55 EBKD55 11.09.2006 4912020845 Deodorantien / Antitranspirantien - Spray nein EBKD55C EBKD55C 11.09.2006 4912020846 Deodorant-Aerosol-Spray (ohne schweißhemmendes Salz) nein EBKD55CC EBKD55CC 11.09.2006 4912020847 Antitranspirant-Aerosol-Spray (mit schweißhemmendem Salz) nein EBKD55CF EBKD55CF 11.09.2006 4912020848 Deodorantien / Antitranspirantien - Roller nein EBKD55F EBKD55F 11.09.2006 4912020849 Deodorant-Roll-On (ohne schweißhemmendes Salz) nein EBKD55FC EBKD55FC 11.09.2006 4912020850 Antitranspirant-Roll-On (mit schweißhemmendem Salz) nein EBKD55FF EBKD55FF 11.09.2006 4912020851 Deodorantien / Antitranspirantien - Stift nein EBKD55I EBKD55I 11.09.2006 4912020852 Deostift (ohne schweißhemmendes Salz) nein EBKD55IC EBKD55IC 11.09.2006 4912020853 Antitranspirant-Stift (mit schweißhemmendem Salz) nein EBKD55IF EBKD55IF 11.09.2006 4912020854 Deodorantien / Antitranspirantien - andere Formen nein EBKD55L EBKD55L 11.09.2006 4912020855 Deodorant - flüssige Presspackung oder Pumpspray nein EBKD55LC EBKD55LC 11.09.2006 4912020856 Antitranspirant - flüssige Presspackung oder Pumpspray nein EBKD55LF EBKD55LF 11.09.2006 4912020857 Antitranspirant Creme nein EBKD55LI EBKD55LI 11.09.2006 4912000370 Make-up-Produkte nein EBKD60 EBKD60 11.09.2006 4912020858 Lippen-Make-up und -pflege nein EBKD60C EBKD60C 11.09.2006 20.10.2008 20.10.2008 TKS_NAME (alt:Lippen - Make-up und -pflege) 4912020859 Lippenstift / Lippencreme (einschließlich Abdeckstifte / Cremes) nein EBKD60CC EBKD60CC 11.09.2006 4912020860 Lippenfarbe und Gloss / Balsam nein EBKD60CF EBKD60CF 11.09.2006 4912020861 Konturenstift nein EBKD60CI EBKD60CI 11.09.2006 4912020862 Lippenlack nein EBKD60CL EBKD60CL
Load more

Recommended publications
  • The In¯Uence of Medication on Erectile Function
    International Journal of Impotence Research (1997) 9, 17±26 ß 1997 Stockton Press All rights reserved 0955-9930/97 $12.00 The in¯uence of medication on erectile function W Meinhardt1, RF Kropman2, P Vermeij3, AAB Lycklama aÁ Nijeholt4 and J Zwartendijk4 1Department of Urology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; 2Department of Urology, Leyenburg Hospital, Leyweg 275, 2545 CH The Hague, The Netherlands; 3Pharmacy; and 4Department of Urology, Leiden University Hospital, P.O. Box 9600, 2300 RC Leiden, The Netherlands Keywords: impotence; side-effect; antipsychotic; antihypertensive; physiology; erectile function Introduction stopped their antihypertensive treatment over a ®ve year period, because of side-effects on sexual function.5 In the drug registration procedures sexual Several physiological mechanisms are involved in function is not a major issue. This means that erectile function. A negative in¯uence of prescrip- knowledge of the problem is mainly dependent on tion-drugs on these mechanisms will not always case reports and the lists from side effect registries.6±8 come to the attention of the clinician, whereas a Another way of looking at the problem is drug causing priapism will rarely escape the atten- combining available data on mechanisms of action tion. of drugs with the knowledge of the physiological When erectile function is in¯uenced in a negative mechanisms involved in erectile function. The way compensation may occur. For example, age- advantage of this approach is that remedies may related penile sensory disorders may be compen- evolve from it. sated for by extra stimulation.1 Diminished in¯ux of In this paper we will discuss the subject in the blood will lead to a slower onset of the erection, but following order: may be accepted.
    [Show full text]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
    USOO6264,917B1 (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness et al. (45) Date of Patent: Jul. 24, 2001 (54) TARGETED ULTRASOUND CONTRAST 5,733,572 3/1998 Unger et al.. AGENTS 5,780,010 7/1998 Lanza et al. 5,846,517 12/1998 Unger .................................. 424/9.52 (75) Inventors: Jo Klaveness; Pál Rongved; Dagfinn 5,849,727 12/1998 Porter et al. ......................... 514/156 Lovhaug, all of Oslo (NO) 5,910,300 6/1999 Tournier et al. .................... 424/9.34 FOREIGN PATENT DOCUMENTS (73) Assignee: Nycomed Imaging AS, Oslo (NO) 2 145 SOS 4/1994 (CA). (*) Notice: Subject to any disclaimer, the term of this 19 626 530 1/1998 (DE). patent is extended or adjusted under 35 O 727 225 8/1996 (EP). U.S.C. 154(b) by 0 days. WO91/15244 10/1991 (WO). WO 93/20802 10/1993 (WO). WO 94/07539 4/1994 (WO). (21) Appl. No.: 08/958,993 WO 94/28873 12/1994 (WO). WO 94/28874 12/1994 (WO). (22) Filed: Oct. 28, 1997 WO95/03356 2/1995 (WO). WO95/03357 2/1995 (WO). Related U.S. Application Data WO95/07072 3/1995 (WO). (60) Provisional application No. 60/049.264, filed on Jun. 7, WO95/15118 6/1995 (WO). 1997, provisional application No. 60/049,265, filed on Jun. WO 96/39149 12/1996 (WO). 7, 1997, and provisional application No. 60/049.268, filed WO 96/40277 12/1996 (WO). on Jun. 7, 1997. WO 96/40285 12/1996 (WO). (30) Foreign Application Priority Data WO 96/41647 12/1996 (WO).
    [Show full text]
  • Prohibited Substances List
    Prohibited Substances List This is the Equine Prohibited Substances List that was voted in at the FEI General Assembly in November 2009 alongside the new Equine Anti-Doping and Controlled Medication Regulations(EADCMR). Neither the List nor the EADCM Regulations are in current usage. Both come into effect on 1 January 2010. The current list of FEI prohibited substances remains in effect until 31 December 2009 and can be found at Annex II Vet Regs (11th edition) Changes in this List : Shaded row means that either removed or allowed at certain limits only SUBSTANCE ACTIVITY Banned Substances 1 Acebutolol Beta blocker 2 Acefylline Bronchodilator 3 Acemetacin NSAID 4 Acenocoumarol Anticoagulant 5 Acetanilid Analgesic/anti-pyretic 6 Acetohexamide Pancreatic stimulant 7 Acetominophen (Paracetamol) Analgesic/anti-pyretic 8 Acetophenazine Antipsychotic 9 Acetylmorphine Narcotic 10 Adinazolam Anxiolytic 11 Adiphenine Anti-spasmodic 12 Adrafinil Stimulant 13 Adrenaline Stimulant 14 Adrenochrome Haemostatic 15 Alclofenac NSAID 16 Alcuronium Muscle relaxant 17 Aldosterone Hormone 18 Alfentanil Narcotic 19 Allopurinol Xanthine oxidase inhibitor (anti-hyperuricaemia) 20 Almotriptan 5 HT agonist (anti-migraine) 21 Alphadolone acetate Neurosteriod 22 Alphaprodine Opiod analgesic 23 Alpidem Anxiolytic 24 Alprazolam Anxiolytic 25 Alprenolol Beta blocker 26 Althesin IV anaesthetic 27 Althiazide Diuretic 28 Altrenogest (in males and gelidngs) Oestrus suppression 29 Alverine Antispasmodic 30 Amantadine Dopaminergic 31 Ambenonium Cholinesterase inhibition 32 Ambucetamide Antispasmodic 33 Amethocaine Local anaesthetic 34 Amfepramone Stimulant 35 Amfetaminil Stimulant 36 Amidephrine Vasoconstrictor 37 Amiloride Diuretic 1 Prohibited Substances List This is the Equine Prohibited Substances List that was voted in at the FEI General Assembly in November 2009 alongside the new Equine Anti-Doping and Controlled Medication Regulations(EADCMR).
    [Show full text]
  • Pharmaceuticals Appendix
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ADAPALENE 106685-40-9 ABANOQUIL 90402-40-7 ADAPROLOL 101479-70-3 ABECARNIL 111841-85-1 ADEMETIONINE 17176-17-9 ABLUKAST 96566-25-5 ADENOSINE PHOSPHATE 61-19-8 ABUNIDAZOLE 91017-58-2 ADIBENDAN 100510-33-6 ACADESINE 2627-69-2 ADICILLIN 525-94-0 ACAMPROSATE 77337-76-9 ADIMOLOL 78459-19-5 ACAPRAZINE 55485-20-6 ADINAZOLAM 37115-32-5 ACARBOSE 56180-94-0 ADIPHENINE 64-95-9 ACEBROCHOL 514-50-1 ADIPIODONE 606-17-7 ACEBURIC ACID 26976-72-7 ADITEREN 56066-19-4 ACEBUTOLOL 37517-30-9 ADITOPRIME 56066-63-8 ACECAINIDE 32795-44-1 ADOSOPINE 88124-26-9 ACECARBROMAL 77-66-7 ADOZELESIN 110314-48-2 ACECLIDINE 827-61-2 ADRAFINIL 63547-13-7 ACECLOFENAC 89796-99-6 ADRENALONE 99-45-6 ACEDAPSONE 77-46-3 AFALANINE 2901-75-9 ACEDIASULFONE SODIUM 127-60-6 AFLOQUALONE 56287-74-2 ACEDOBEN 556-08-1 AFUROLOL 65776-67-2 ACEFLURANOL 80595-73-9 AGANODINE 86696-87-9 ACEFURTIAMINE 10072-48-7 AKLOMIDE 3011-89-0 ACEFYLLINE CLOFIBROL 70788-27-1
    [Show full text]
  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
    MTC eHealth DSI [eHDSI v2.2.2-OR] eHealth DSI – Master Value Set Catalogue Responsible : eHDSI Solution Provider PublishDate : Wed Nov 08 16:16:10 CET 2017 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 1 of 490 MTC Table of Contents epSOSActiveIngredient 4 epSOSAdministrativeGender 148 epSOSAdverseEventType 149 epSOSAllergenNoDrugs 150 epSOSBloodGroup 155 epSOSBloodPressure 156 epSOSCodeNoMedication 157 epSOSCodeProb 158 epSOSConfidentiality 159 epSOSCountry 160 epSOSDisplayLabel 167 epSOSDocumentCode 170 epSOSDoseForm 171 epSOSHealthcareProfessionalRoles 184 epSOSIllnessesandDisorders 186 epSOSLanguage 448 epSOSMedicalDevices 458 epSOSNullFavor 461 epSOSPackage 462 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 2 of 490 MTC epSOSPersonalRelationship 464 epSOSPregnancyInformation 466 epSOSProcedures 467 epSOSReactionAllergy 470 epSOSResolutionOutcome 472 epSOSRoleClass 473 epSOSRouteofAdministration 474 epSOSSections 477 epSOSSeverity 478 epSOSSocialHistory 479 epSOSStatusCode 480 epSOSSubstitutionCode 481 epSOSTelecomAddress 482 epSOSTimingEvent 483 epSOSUnits 484 epSOSUnknownInformation 487 epSOSVaccine 488 © eHealth DSI eHDSI Solution Provider v2.2.2-OR Wed Nov 08 16:16:10 CET 2017 Page 3 of 490 MTC epSOSActiveIngredient epSOSActiveIngredient Value Set ID 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 TRANSLATIONS Code System ID Code System Version Concept Code Description (FSN) 2.16.840.1.113883.6.73 2017-01 A ALIMENTARY TRACT AND METABOLISM 2.16.840.1.113883.6.73 2017-01
    [Show full text]
  • Safety, Tolerability and Pharmacokinetics of Intravaginal Pentamycin
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by edoc Pharmacology Chemotherapy 2010;56:190–196 Received: March 20, 2009 DOI: 10.1159/000316329 Accepted after revision: January 12, 2010 Published online: June 10, 2010 Safety, Tolerability and Pharmacokinetics of Intravaginal Pentamycin a a c b B. Frey Tirri J. Bitzer B. Geudelin J. Drewe a b Departments of Obstetrics and Gynecology, and Clinical Pharmacology, University Hospital Basel, and c Mediante GmbH, Basel , Switzerland Key Words cin does not cause adverse reactions compared with vehicle -Antimicrobial agents ؒ Pentamycin ؒ Pharmacokinetics ؒ and is not absorbed through the intact or the inflamed va Polyene antifungal antibiotic ؒ Vaginal infections gina. Copyright © 2010 S. Karger AG, Basel Abstract Background/Aims: Intravaginal pentamycin is a polyene Introduction macrolide with a broad spectrum of antimicrobial activity and is effective in various forms of infectious vaginitis. We The most common vaginal disorders include vaginal evaluated the safety, tolerability and pharmacokinetics of candidiasis, vaginal trichomoniasis and bacterial vagino- escalating doses of this product. Methods: Nineteen healthy sis [1–5] . Forms of infectious vaginitis sustained by mixed volunteers were randomized to receive double blind one of micro-organisms are also observed frequently [6] . Vagi- five doses of intravaginal pentamycin (3, 10, 30, 60 or 100 mg) nal infections can be successfully treated by using one or or the corresponding dose of pentamycin vehicle daily for more pathogen-specific antimicrobials [1, 3, 7–9] , but, be- 6 days. Patients with symptomatic vaginitis received a single fore vaginitis is treated, the cause must be ascertained by dose of 60 (n = 6) or 100 mg (n = 6) of intravaginal penta- using appropriate laboratory tests [1, 2, 6, 7, 10] .
    [Show full text]
  • Pharmaceutical Appendix to the Tariff Schedule 2
    Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. ABACAVIR 136470-78-5 ACIDUM LIDADRONICUM 63132-38-7 ABAFUNGIN 129639-79-8 ACIDUM SALCAPROZICUM 183990-46-7 ABAMECTIN 65195-55-3 ACIDUM SALCLOBUZICUM 387825-03-8 ABANOQUIL 90402-40-7 ACIFRAN 72420-38-3 ABAPERIDONUM 183849-43-6 ACIPIMOX 51037-30-0 ABARELIX 183552-38-7 ACITAZANOLAST 114607-46-4 ABATACEPTUM 332348-12-6 ACITEMATE 101197-99-3 ABCIXIMAB 143653-53-6 ACITRETIN 55079-83-9 ABECARNIL 111841-85-1 ACIVICIN 42228-92-2 ABETIMUSUM 167362-48-3 ACLANTATE 39633-62-0 ABIRATERONE 154229-19-3 ACLARUBICIN 57576-44-0 ABITESARTAN 137882-98-5 ACLATONIUM NAPADISILATE 55077-30-0 ABLUKAST 96566-25-5 ACODAZOLE 79152-85-5 ABRINEURINUM 178535-93-8 ACOLBIFENUM 182167-02-8 ABUNIDAZOLE 91017-58-2 ACONIAZIDE 13410-86-1 ACADESINE 2627-69-2 ACOTIAMIDUM 185106-16-5 ACAMPROSATE 77337-76-9
    [Show full text]
  • United States Patent 19 [11] 3,957,754 Aszalos Et Al
    United States Patent 19 [11] 3,957,754 ASzalos et al. (45) May 18, 1976 54 COMPLEXES OF ANTIFUNGAL POLYENE 3,777,018 12/1973 Gordon et al................ 260/210 AB ANTIBOTCS FOREIGN PATENTS OR APPLICATIONS (75) Inventors: Adorjan Aszalos, Princeton; John Vandeputte, Milltown, both of N.J. 795,482 5/1958 United Kingdom.......... 260/210 AB (73) Assignee: E. R. Squibb & Sons, Inc., OTHER PUBLICATIONS Princeton, N.J. 22 Filed: Jan. 13, 1975 Mazor et al. “Chem. Abst." Vol. 57, 1962, p. 956g. 21 Appl. No.: 540,750 Primary Examiner-Johnnie R. Brown Related U.S. Application Data Attorney, Agent, or Firm-Lawrence S. Levinson; 62 Division of Ser. No. 100,492, Dec. 21, 1970, Pat. No. Merle J. Smith; Stephen B. Davis 3,879,374. 52 U.S. Cl........................... 260/210 AB; 424/180; 57) ABSTRACT 424/181 51 int. Cl'.......................................... C07H 15/20 Disclosed herein are complexes of polyene antibiotics 58 Field of Search.............. 260/210 AB; 424/117, which are soluble in alcohol or in water and alcohol. 424/119 These complexes are prepared in alcoholic solutions and have been found to be useful as antifungal agents 56) References Cited which can be orally administered. UNITED STATES PATENTS 6 Claims, No Drawings 2,865,807 12, 1958 Dutcher et al............... 260/20 AB 3,957,754 2 Alcohols that can be utilized to carry out the reaction COMPLEXES OF ANTIFUNGAL POLYENE are the lower alkyl alcohols of from 1 to 6 carbons such ANTBIOTICS as methanol, ethanol, isopropanol, isobutanol, butanol, This is a division of Ser.
    [Show full text]
  • Marrakesh Agreement Establishing the World Trade Organization
    No. 31874 Multilateral Marrakesh Agreement establishing the World Trade Organ ization (with final act, annexes and protocol). Concluded at Marrakesh on 15 April 1994 Authentic texts: English, French and Spanish. Registered by the Director-General of the World Trade Organization, acting on behalf of the Parties, on 1 June 1995. Multilat ral Accord de Marrakech instituant l©Organisation mondiale du commerce (avec acte final, annexes et protocole). Conclu Marrakech le 15 avril 1994 Textes authentiques : anglais, français et espagnol. Enregistré par le Directeur général de l'Organisation mondiale du com merce, agissant au nom des Parties, le 1er juin 1995. Vol. 1867, 1-31874 4_________United Nations — Treaty Series • Nations Unies — Recueil des Traités 1995 Table of contents Table des matières Indice [Volume 1867] FINAL ACT EMBODYING THE RESULTS OF THE URUGUAY ROUND OF MULTILATERAL TRADE NEGOTIATIONS ACTE FINAL REPRENANT LES RESULTATS DES NEGOCIATIONS COMMERCIALES MULTILATERALES DU CYCLE D©URUGUAY ACTA FINAL EN QUE SE INCORPOR N LOS RESULTADOS DE LA RONDA URUGUAY DE NEGOCIACIONES COMERCIALES MULTILATERALES SIGNATURES - SIGNATURES - FIRMAS MINISTERIAL DECISIONS, DECLARATIONS AND UNDERSTANDING DECISIONS, DECLARATIONS ET MEMORANDUM D©ACCORD MINISTERIELS DECISIONES, DECLARACIONES Y ENTEND MIENTO MINISTERIALES MARRAKESH AGREEMENT ESTABLISHING THE WORLD TRADE ORGANIZATION ACCORD DE MARRAKECH INSTITUANT L©ORGANISATION MONDIALE DU COMMERCE ACUERDO DE MARRAKECH POR EL QUE SE ESTABLECE LA ORGANIZACI N MUND1AL DEL COMERCIO ANNEX 1 ANNEXE 1 ANEXO 1 ANNEX
    [Show full text]
  • Alphabetical Listing of ATC Drugs & Codes
    Alphabetical Listing of ATC drugs & codes. Introduction This file is an alphabetical listing of ATC codes as supplied to us in November 1999. It is supplied free as a service to those who care about good medicine use by mSupply support. To get an overview of the ATC system, use the “ATC categories.pdf” document also alvailable from www.msupply.org.nz Thanks to the WHO collaborating centre for Drug Statistics & Methodology, Norway, for supplying the raw data. I have intentionally supplied these files as PDFs so that they are not quite so easily manipulated and redistributed. I am told there is no copyright on the files, but it still seems polite to ask before using other people’s work, so please contact <[email protected]> for permission before asking us for text files. mSupply support also distributes mSupply software for inventory control, which has an inbuilt system for reporting on medicine usage using the ATC system You can download a full working version from www.msupply.org.nz Craig Drown, mSupply Support <[email protected]> April 2000 A (2-benzhydryloxyethyl)diethyl-methylammonium iodide A03AB16 0.3 g O 2-(4-chlorphenoxy)-ethanol D01AE06 4-dimethylaminophenol V03AB27 Abciximab B01AC13 25 mg P Absorbable gelatin sponge B02BC01 Acadesine C01EB13 Acamprosate V03AA03 2 g O Acarbose A10BF01 0.3 g O Acebutolol C07AB04 0.4 g O,P Acebutolol and thiazides C07BB04 Aceclidine S01EB08 Aceclidine, combinations S01EB58 Aceclofenac M01AB16 0.2 g O Acefylline piperazine R03DA09 Acemetacin M01AB11 Acenocoumarol B01AA07 5 mg O Acepromazine N05AA04
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]